Endoscopic Retrograde Cholangiopancreatography (ERCP) devices are medical instruments and tools used in the diagnostic and therapeutic procedure known as ERCP. ERCP is a specialized endoscopic technique used to visualize and treat disorders of the bile ducts, pancreatic duct, and gallbladder. The procedure involves the use of an endoscope, a flexible tube with a light and camera at the tip, which is passed through the mouth, esophagus, stomach, and into the duodenum.
The global Endoscopic Retrograde Cholangiopancreatography Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The demand for ERCP devices is influenced by the overall number of ERCP procedures performed globally. Factors such as the prevalence of biliary and pancreatic disorders, the aging population, and the adoption of minimally invasive procedures contribute to the growth of ERCP procedures and, consequently, the demand for related devices.
Report Covers:
This report presents an overview of global market for Endoscopic Retrograde Cholangiopancreatography Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Endoscopic Retrograde Cholangiopancreatography Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Endoscopic Retrograde Cholangiopancreatography Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Endoscopic Retrograde Cholangiopancreatography Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Endoscopic Retrograde Cholangiopancreatography Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Endoscopic Retrograde Cholangiopancreatography Devices sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Olympus
CONMED
Hobbs Medical
Merit Endotek
Telemed Systems
STERIS
Segment by Type
Biliary Stone Removal Basket
Biliary Dilation Balloon
Biliary and Pancreatic Stent
Biliary Lithotripter
ERCP Cannula
Segment by Application
Hospital
Clinic
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Endoscopic Retrograde Cholangiopancreatography Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Endoscopic Retrograde Cholangiopancreatography Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endoscopic Retrograde Cholangiopancreatography Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Endoscopic Retrograde Cholangiopancreatography Devices Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Biliary Stone Removal Basket
1.2.3 Biliary Dilation Balloon
1.2.4 Biliary and Pancreatic Stent
1.2.5 Biliary Lithotripter
1.2.6 ERCP Cannula
1.3 麻豆原创 by Application
1.3.1 Global Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales Estimates and Forecasts 2019-2030
2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region
2.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region (2019-2024)
2.2.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region (2025-2030)
2.2.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales Estimates and Forecasts 2019-2030
2.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region
2.4.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region (2019-2024)
2.4.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region (2025-2030)
2.4.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Manufacturers
3.1.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Manufacturers (2019-2024)
3.1.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Endoscopic Retrograde Cholangiopancreatography Devices in 2023
3.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Manufacturers
3.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Manufacturers (2019-2024)
3.2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Endoscopic Retrograde Cholangiopancreatography Devices Revenue in 2023
3.3 Global Key Players of Endoscopic Retrograde Cholangiopancreatography Devices, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Endoscopic Retrograde Cholangiopancreatography Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Endoscopic Retrograde Cholangiopancreatography Devices, Product Offered and Application
3.8 Global Key Manufacturers of Endoscopic Retrograde Cholangiopancreatography Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Type
4.1.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Historical Sales by Type (2019-2024)
4.1.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Forecasted Sales by Type (2025-2030)
4.1.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Type
4.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Historical Revenue by Type (2019-2024)
4.2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Forecasted Revenue by Type (2025-2030)
4.2.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Price by Type
4.3.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Price by Type (2019-2024)
4.3.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application
5.1.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Historical Sales by Application (2019-2024)
5.1.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Forecasted Sales by Application (2025-2030)
5.1.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application
5.2.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Historical Revenue by Application (2019-2024)
5.2.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Forecasted Revenue by Application (2025-2030)
5.2.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Endoscopic Retrograde Cholangiopancreatography Devices Price by Application
5.3.1 Global Endoscopic Retrograde Cholangiopancreatography Devices Price by Application (2019-2024)
5.3.2 Global Endoscopic Retrograde Cholangiopancreatography Devices Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Type
6.1.1 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices Sales by Type (2019-2030)
6.1.2 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Type (2019-2030)
6.2 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Application
6.2.1 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application (2019-2030)
6.2.2 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application (2019-2030)
6.3 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Country
6.3.1 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country (2019-2030)
6.3.3 US & Canada Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Type
7.1.1 Europe Endoscopic Retrograde Cholangiopancreatography Devices Sales by Type (2019-2030)
7.1.2 Europe Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Type (2019-2030)
7.2 Europe Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Application
7.2.1 Europe Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application (2019-2030)
7.2.2 Europe Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application (2019-2030)
7.3 Europe Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Country
7.3.1 Europe Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country (2019-2030)
7.3.3 Europe Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size
8.1.1 China Endoscopic Retrograde Cholangiopancreatography Devices Sales (2019-2030)
8.1.2 China Endoscopic Retrograde Cholangiopancreatography Devices Revenue (2019-2030)
8.2 China Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Application
8.2.1 China Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application (2019-2030)
8.2.2 China Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Type
9.1.1 Asia Endoscopic Retrograde Cholangiopancreatography Devices Sales by Type (2019-2030)
9.1.2 Asia Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Type (2019-2030)
9.2 Asia Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Application
9.2.1 Asia Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application (2019-2030)
9.2.2 Asia Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application (2019-2030)
9.3 Asia Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region
9.3.1 Asia Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Region (2019-2030)
9.3.3 Asia Endoscopic Retrograde Cholangiopancreatography Devices Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country
10.3.1 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Endoscopic Retrograde Cholangiopancreatography Devices Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Information
11.1.2 Boston Scientific Overview
11.1.3 Boston Scientific Endoscopic Retrograde Cholangiopancreatography Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Boston Scientific Endoscopic Retrograde Cholangiopancreatography Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boston Scientific Recent Developments
11.2 Cook Medical
11.2.1 Cook Medical Company Information
11.2.2 Cook Medical Overview
11.2.3 Cook Medical Endoscopic Retrograde Cholangiopancreatography Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Cook Medical Endoscopic Retrograde Cholangiopancreatography Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cook Medical Recent Developments
11.3 Olympus
11.3.1 Olympus Company Information
11.3.2 Olympus Overview
11.3.3 Olympus Endoscopic Retrograde Cholangiopancreatography Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Olympus Endoscopic Retrograde Cholangiopancreatography Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Olympus Recent Developments
11.4 CONMED
11.4.1 CONMED Company Information
11.4.2 CONMED Overview
11.4.3 CONMED Endoscopic Retrograde Cholangiopancreatography Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 CONMED Endoscopic Retrograde Cholangiopancreatography Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CONMED Recent Developments
11.5 Hobbs Medical
11.5.1 Hobbs Medical Company Information
11.5.2 Hobbs Medical Overview
11.5.3 Hobbs Medical Endoscopic Retrograde Cholangiopancreatography Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Hobbs Medical Endoscopic Retrograde Cholangiopancreatography Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hobbs Medical Recent Developments
11.6 Merit Endotek
11.6.1 Merit Endotek Company Information
11.6.2 Merit Endotek Overview
11.6.3 Merit Endotek Endoscopic Retrograde Cholangiopancreatography Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Merit Endotek Endoscopic Retrograde Cholangiopancreatography Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merit Endotek Recent Developments
11.7 Telemed Systems
11.7.1 Telemed Systems Company Information
11.7.2 Telemed Systems Overview
11.7.3 Telemed Systems Endoscopic Retrograde Cholangiopancreatography Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Telemed Systems Endoscopic Retrograde Cholangiopancreatography Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Telemed Systems Recent Developments
11.8 STERIS
11.8.1 STERIS Company Information
11.8.2 STERIS Overview
11.8.3 STERIS Endoscopic Retrograde Cholangiopancreatography Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 STERIS Endoscopic Retrograde Cholangiopancreatography Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 STERIS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Endoscopic Retrograde Cholangiopancreatography Devices Industry Chain Analysis
12.2 Endoscopic Retrograde Cholangiopancreatography Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Endoscopic Retrograde Cholangiopancreatography Devices Production Mode & Process
12.4 Endoscopic Retrograde Cholangiopancreatography Devices Sales and 麻豆原创ing
12.4.1 Endoscopic Retrograde Cholangiopancreatography Devices Sales Channels
12.4.2 Endoscopic Retrograde Cholangiopancreatography Devices Distributors
12.5 Endoscopic Retrograde Cholangiopancreatography Devices Customers
13 麻豆原创 Dynamics
13.1 Endoscopic Retrograde Cholangiopancreatography Devices Industry Trends
13.2 Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Drivers
13.3 Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Challenges
13.4 Endoscopic Retrograde Cholangiopancreatography Devices 麻豆原创 Restraints
14 Key Findings in The Global Endoscopic Retrograde Cholangiopancreatography Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Boston Scientific
Cook Medical
Olympus
CONMED
Hobbs Medical
Merit Endotek
Telemed Systems
STERIS
听
听
*If Applicable.
